A University of Minnesota Medical School research team has found that giving iron supplements to children living with human immunodeficiency virus (HIV) in sub-Saharan Africa could be an important first step in optimizing ...
Oct 31, 2024
0
0
All mammals can develop cancer, the rapid growth of harmful cells that can overtake normal cells and compromise their ability to function. Scientists have long observed that a species of nearly-hairless subterranean rodents ...
Oct 30, 2024
0
17
Ancient viral remnants in the human genome are activated during pregnancy and after significant bleeding in order to increase blood cell production, an important step toward defining the purpose of "junk DNA" in humans, according ...
Oct 25, 2024
0
200
A multiomic analysis led by the IrsiCaixa AIDS Research Institute has uncovered genetic and immune mechanisms in some HIV-positive individuals, known as viremic non-progressors (VNPs), to avoid disease progression without ...
In the late 1980s, Linda Rose Frank began working with HIV-positive individuals at the University of Pittsburgh. At the time, those affected were mainly young men with a terrifying prognosis.
Sep 2, 2024
0
0
MacArthur Flournoy has lived with HIV since 1988, though a nurse at the time told him that he would likely die within two years.
Jul 29, 2024
0
0
Researchers in George Mason University's Center for Infectious Disease Research (CIDR) and Tulane National Primate Research Center have conducted a breakthrough proof-of-concept study, published in the journal Gene Therapy, ...
Jul 24, 2024
0
19
A study led by researchers at the American Cancer Society (ACS) finds four in 10 cancer cases and about one-half of all cancer deaths in adults 30 years old and older in the United States (or 713,340 cancer cases and 262,120 ...
Jul 11, 2024
0
192
A multinational team led by Weill Cornell Medicine investigators developed a test that will help measure the persistence of HIV in people affected by viral strains found predominantly in Africa—a vital tool in the search ...
Jul 2, 2024
0
55
A team from Houston Methodist Research Institute recently showed that a nanofluidic implant delivered an HIV drug that achieved more potency than other forms of drug administration (oral) and other HIV drugs.
Mar 26, 2024
0
0
